Ohana Biosciences has built a proprietary, world-leading sperm biology platform to address significant needs and transform the field of reproductive medicine. Driven by a robust scientific understanding of spermatogenesis and sperm biology, our platform leverages the complexities associated with sperm heterogeneity and function.

Ohana is developing life-changing products that will increase the success rate of assisted reproductive technologies (ARTs); provide novel non-hormonal, reversible, long-lasting male contraception; and decrease the risk of disease transmission from father to offspring.

Ohana was founded by Flagship Pioneering and is located in Cambridge, MA.